Tramadol differs from classical mu agonists in that it also acts as a(n) __________ reuptake inhibitor, contributing to its analgesic effect.

Explanation

## Tramadol's Dual Mechanism of Action **Key Point:** Tramadol is a weak mu opioid agonist AND a monoamine reuptake inhibitor. Its dual action on **serotonin and noradrenaline** reuptake (SNRI-like activity) enhances analgesia beyond what mu agonism alone would provide. ### Tramadol's Pharmacological Profile | Property | Details | |---|---| | **Mu agonism** | Weak (10–20% potency of morphine) | | **Serotonin reuptake inhibition** | Increases synaptic 5-HT, enhances descending inhibitory pain pathways | | **Noradrenaline reuptake inhibition** | Increases synaptic NA, activates locus coeruleus-mediated analgesia | | **Clinical effect** | Analgesia from both opioid + monoaminergic mechanisms | | **Unique risk** | Serotonin syndrome (especially with SSRIs, MAOIs) | **High-Yield:** Tramadol's serotonin reuptake inhibition is clinically significant because: 1. It increases the risk of **serotonin syndrome** when combined with SSRIs, SNRIs, or MAOIs. 2. It explains why tramadol is effective for neuropathic pain (monoamine-dependent), not just nociceptive pain. 3. It is the reason tramadol is contraindicated or used with extreme caution in patients on serotonergic drugs. **Mnemonic:** **SNIT** — **S**erotonin and **N**oradrenaline **I**nhibi**T**ion (reuptake) is what makes Tramadol special. **Clinical Pearl:** Tramadol is often used for moderate pain and neuropathic pain because its monoaminergic activity complements opioid analgesia. However, the risk of serotonin syndrome makes it contraindicated in patients already on SSRIs or MAOIs without careful monitoring. **Warning:** Do NOT confuse tramadol with pure mu agonists (morphine, codeine, fentanyl). Tramadol's weak mu activity means it is NOT suitable for severe acute pain requiring rapid, potent opioid analgesia.